Floatz logo

Interferon Beta

Macular Edema

Heidelberg Universityprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Macular Edema cohort.

Asset / SponsorPhaseRating
METHOTREXATE
Heidelberg University
Phase 3BB
immunoglobulin G1, anti-(human vascular endothelial growth factor) Fab fragment (human-mouse monoclonal rhuFAB V2 1-chain), disulfide with human-mouse monoclonal rhuFAB V2 light chain
Novartis Pharmaceuticals
Phase 3BB
Dex Ps Dds®
Allergan
Phase 2B
Ozurdex
Arman Mashayekhi
Phase 2CCC

Same molecule, other indications

Interferon Beta is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
69 / 100
View asset →
intermediate uveitisDormant
BB
Indicative ·
64 / 100
View asset →
multiple sclerosisDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →